203 related articles for article (PubMed ID: 30890839)
1. Assessment of changes in masseter muscle by three-dimensional close-range photogrammetry after Botulinum toxin type-A injection: A case report with review of literature.
Bayrak NB; Zeybek M; Sanlioglu I; Dolanmaz D
J Pak Med Assoc; 2019 Mar; 69(3):418-422. PubMed ID: 30890839
[TBL] [Abstract][Full Text] [Related]
2. [Quantitative analysis based on three-dimensional stereophotogrammetry in the observation of curative effect of botulinum toxin A on masseter hypertrophy].
Xue Z; Zeng W; Chen Z; Han Y
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):272-5. PubMed ID: 30044570
[TBL] [Abstract][Full Text] [Related]
3. RimabotulinumtoxinB versus OnabotulinumtoxinA in the treatment of masseter hypertrophy: a 24-week double-blind randomized split-face study.
Lee DH; Jin SP; Cho S; Feneran A; Youn CS; Won CH; Park GH; Kim BW; An J; Chang SE; Lee MW
Dermatology; 2013; 226(3):227-32. PubMed ID: 23774030
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional stereophotogrammetric method of quantifying the effect of botulinum toxin type A injections on masseter hypertrophy.
Adriaens J; van Loon B; Ingels KJ; Bergé SJ; Maal TJ
Plast Reconstr Surg; 2012 Aug; 130(2):376e-378e. PubMed ID: 22842446
[No Abstract] [Full Text] [Related]
6. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
Aydil B; Başaran B; Unsaler S; Süoğlu Y
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
[TBL] [Abstract][Full Text] [Related]
7. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A].
Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
Scali C; Carruthers A; Malpas D; Humphrey S
Dermatol Surg; 2015 Nov; 41(11):1300-8. PubMed ID: 26469200
[TBL] [Abstract][Full Text] [Related]
9. Prolonging the duration of masseter muscle reduction by adjusting the masticatory movements after the treatment of masseter muscle hypertrophy with botulinum toxin type a injection.
Wei J; Xu H; Dong J; Li Q; Dai C
Dermatol Surg; 2015 Jan; 41 Suppl 1():S101-9. PubMed ID: 25548838
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for masseter hypertrophy.
Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of a Novel Botulinum Toxin A for Masseter Reduction: A Randomized, Double-Blind, Placebo-Controlled, Optimal Dose-Finding Study.
Hong JY; Jeong GJ; Kwon TR; Kim JH; Li K; Kim BJ
Dermatol Surg; 2021 Jan; 47(1):e5-e9. PubMed ID: 33347002
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin for masseter hypertrophy.
Fedorowicz Z; van Zuuren EJ; Schoones J
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD007510. PubMed ID: 24018587
[TBL] [Abstract][Full Text] [Related]
13. Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A.
Nilesh K; Dharamsi R; Patil P; Mate P
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462041
[TBL] [Abstract][Full Text] [Related]
14. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
[TBL] [Abstract][Full Text] [Related]
15. Masseter Muscle Volume Changes Evaluated by 3-Dimensional Computed Tomography After Repeated Botulinum Toxin A Injections in Patients With Square Facial Morphology.
Chang CS; Lin S; Wallace CG; Hsiao YC; Lin CM; Kang GC; Chen ZC; Chen PK; Lo LJ; Chen YR; Chen JP
Ann Plast Surg; 2019 Jan; 82(1S Suppl 1):S29-S32. PubMed ID: 30540604
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring.
Kundu N; Kothari R; Shah N; Sandhu S; Tripathy DM; Galadari H; Gold MH; Goldman MP; Kassir M; Schepler H; Grabbe S; Goldust M
J Cosmet Dermatol; 2022 May; 21(5):1849-1856. PubMed ID: 35176198
[TBL] [Abstract][Full Text] [Related]
17. Commentary on a Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
Cox SE
Dermatol Surg; 2015 Nov; 41(11):1309. PubMed ID: 26448313
[No Abstract] [Full Text] [Related]
18. Change of distribution and timing of bite force after botulinum toxin type A injection evaluated by a computerized occlusion analysis system.
Song JH; Cho ES; Kim ST; Ahn HJ
Yonsei Med J; 2014 Jul; 55(4):1123-9. PubMed ID: 24954346
[TBL] [Abstract][Full Text] [Related]
19. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-Guided Botulinum Neurotoxin Injection for Masseter Hypertrophy Based on the Structural Pattern of Deep Inferior Tendon and Masseteric Contraction.
Wang YH; Chang SL; Hu S; Huang YL
Plast Reconstr Surg; 2022 Jul; 150(1):240e-242e. PubMed ID: 35767638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
